PR Newswire
AUSTIN, Texas, Aug. 1, 2017
AUSTIN, Texas, Aug. 1, 2017 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Valerie Palmieri, President and Chief Executive Officer, will provide a corporate overview at the Canaccord Genuity 37th Annual Growth Conference, being held August 9-10 in Boston, Massachusetts.
Presentation Details |
|
Date: |
Thursday, August 10 |
Time: |
1:00pm Eastern Time |
Location: |
InterContinental Boston Hotel, Hong Kong Room |
About Vermillion
Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with critical disease improve their overall health outcomes.
Investor Relations Contact:
Michael Wood
LifeSci Advisors LLC
646-597-6983
[email protected]
View original content:http://www.prnewswire.com/news-releases/vermillion-to-present-at-the-canaccord-genuity-37th-annual-growth-conference-on-august-10th-300497614.html
SOURCE Vermillion, Inc.
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member